<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2664-2891</journal-id>
<journal-title><![CDATA[Revista científica ciencias de la salud]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. cient. cienc. salud]]></abbrev-journal-title>
<issn>2664-2891</issn>
<publisher>
<publisher-name><![CDATA[Universidad del Pacífico]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2664-28912023000100002</article-id>
<article-id pub-id-type="doi">10.53732/rccsalud/2023.e5101</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Características clínico-epidemiológicas de pacientes fallecidos por COVID-19 en un hospital de referencia en Paraguay entre enero de 2021 a julio de 2022]]></article-title>
<article-title xml:lang="en"><![CDATA[Clinical and epidemiological characteristics of patients who died from COVID-19 in a referral hospital in Paraguay between January 2021 and July 2022]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Montiel]]></surname>
<given-names><![CDATA[Dora]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Samudio]]></surname>
<given-names><![CDATA[Margarita]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Torres]]></surname>
<given-names><![CDATA[Estela]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Jarolin]]></surname>
<given-names><![CDATA[Magali]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Taboada]]></surname>
<given-names><![CDATA[Verónica]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Sánchez]]></surname>
<given-names><![CDATA[Luis]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital Nacional Departamento de Medicina Interna ]]></institution>
<addr-line><![CDATA[Itauguá ]]></addr-line>
<country>Paraguay</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad del Pacífico Dirección de Investigación ]]></institution>
<addr-line><![CDATA[Asunción ]]></addr-line>
<country>Paraguay</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2023</year>
</pub-date>
<volume>5</volume>
<fpage>2</fpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.iics.una.py/scielo.php?script=sci_arttext&amp;pid=S2664-28912023000100002&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.iics.una.py/scielo.php?script=sci_abstract&amp;pid=S2664-28912023000100002&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.iics.una.py/scielo.php?script=sci_pdf&amp;pid=S2664-28912023000100002&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN Introducción. La pandemia por COVID-19 desde su inicio hasta el 13 de agosto de 2022, ha causado 19.478 muertes en Paraguay, con una tasa de letalidad de 2,78%. El objetivo del estudio es comparar las características de los pacientes fallecidos por COVID-19 en dos años, enero-diciembre, 2021 y enero-julio 2022. Material y Método. Estudio analítico retrospectivo de corte transverso de pacientes adultos y pediátricos fallecidos por COVID-19 confirmados por RT-PCR en hisopados nasofaríngeos que estaban internados en el área respiratoria del Hospital Nacional de Itauguá. Resultados. De 5265 pacientes internados con COVID-19, fallecieron 1512, siendo la letalidad global de 28,7%, en el 2021 fue 26,3% (1164/4423) y 41,3% (348/842) en el 2022. Hubo mayor porcentaje de varones (53,6%) entre los fallecidos, significativamente mayor (p=0.045) en el 2022 (58,3%) que en el 2021 (52,2%). El 69% de los fallecidos eran mayores de 60 años en el 2022 y 48,3% en 2021. El 79,2% de los pacientes tenía algún factor de riesgo, que fue mayor en el 2022 (84,3%) que en el 2021 (77,7%), sobre todo, HTA (54,3% vs 42,2%), cardiopatía (15,8% vs 9,7%), ERC (14,4% vs 5,4%), EPOC (11,5% vs 5,4%), inmunodeficiencia (6,3% vs 2,5%) y enfermedad neurológica (3,4% vs 1,5%). La necesidad de ARM fue significativamente (p &lt;0,001) mayor en el 2022 (50,3%) que en el 2021 (31,1%). Conclusión. Se observó una letalidad global elevada en un hospital de referencia en Paraguay con los predictores de mortalidad similares a lo reportado a nivel mundial.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT Introduction. The COVID-19 pandemic from its beginning until August 13, 2022, has caused 19,478 deaths in Paraguay with a fatality rate of 2.78%. The objective of the study is to compare the characteristics of patients who died from COVID-19 in two years, January-December 2021 and January-July 2022. Material and Method. A retrospective cross-sectional analytical study of adult and pediatric patients who died from COVID-19 hospitalized in the respiratory area of the hospital. The patients were confirmed by RT-PCR in nasopharyngeal swabs. Results. Out of 5265 patients hospitalized with COVID-19, 1512 died, yielding an overall lethality rate of 28.7%, in 2021 was 26.3% (1164/4423) and 41.3% (348/842) in 2022. There was a higher percentage of men (53, 6%) among the deceased, significantly higher (p=0.045) in 2022 (58.3%) than in 2021 (52.2%); 69% of the deceased were over 60 years of age in 2022 and 48.3% in 2021; 79.2% of the patients had some risk factor, significantly higher in 2022 (84.3%) than in 2021 (77.7%), especially in AHT (54.3% vs 42.2%), heart disease (15.8% vs 9.7%), CKD (14.4% vs 5.4%), COPD (11.5% vs 5.4%), immunodeficiency (6.3% vs 2.5%) and neurological disease (3.4% vs 1.5%). The need for MRA was significantly (p &lt;0.001) higher in 2022 (50.3%) than in 2021 (31.1%). Conclusion. A high global lethality rate was observed in a reference hospital in Paraguay with mortality predictors similar to those reported worldwide.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[mortalidad]]></kwd>
<kwd lng="es"><![CDATA[COVID-19]]></kwd>
<kwd lng="es"><![CDATA[factores de riesgo.]]></kwd>
<kwd lng="en"><![CDATA[mortality]]></kwd>
<kwd lng="en"><![CDATA[COVID-19]]></kwd>
<kwd lng="en"><![CDATA[risk factor.]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="book">
<source><![CDATA[Sala de Situación Epidemiológica COVID-19]]></source>
<year></year>
<publisher-name><![CDATA[DGVS]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Grasselli]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Greco]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Zanella]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Albano]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Antonelli]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Bellani]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<source><![CDATA[Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy]]></source>
<year>2020</year>
<volume>180</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>1345-55</page-range><publisher-name><![CDATA[JAMA Intern Med]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Garg]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[O'Halloran]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Whitaker]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Pham]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Anderson]]></surname>
<given-names><![CDATA[EJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Risk Factors for Intensive Care Unit Admission and In-hospital Mortality Among Hospitalized Adults Identified through the US Coronavirus Disease 2019 (COVID-19)]]></article-title>
<source><![CDATA[Clin Infect Dis.]]></source>
<year>2021</year>
<volume>72</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>e206-14</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arulanandam]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Beladi]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[ChakrGraabarti]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[COVID-19 mortality and the overweight: Cross-Country Evidence]]></article-title>
<source><![CDATA[Public Health Pract]]></source>
<year>2021</year>
<volume>2</volume>
<numero>2100179</numero>
<issue>2100179</issue>
<page-range>1-4</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kumar]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Arora]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Sharma]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Anikhindi]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
<name>
<surname><![CDATA[Bansal]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Is diabetes mellitus associated with mortality and severity of COVID-19?]]></article-title>
<source><![CDATA[A meta-analysis. Diabetes MetabSyndr]]></source>
<year>2020</year>
<volume>14</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>535-45</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Landstra]]></surname>
<given-names><![CDATA[CP]]></given-names>
</name>
<name>
<surname><![CDATA[de Koning]]></surname>
<given-names><![CDATA[EJP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course]]></article-title>
<source><![CDATA[Front Endocrinol (Lausanne)]]></source>
<year>2021</year>
<volume>12</volume>
<page-range>649525</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zhou]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Chi]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Lv]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (Covid-19)]]></article-title>
<source><![CDATA[Diabetes Metab Res Rev]]></source>
<year>2021</year>
<volume>37</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Franchini]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Bongiovanni]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Cruciani]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mortality from COVID-19]]></article-title>
<source><![CDATA[Ann Ig]]></source>
<year>2021</year>
<volume>33</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>521-3</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Elliott]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Bodinier]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Whitaker]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Delpierre]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Vermeulen]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[COVID-19 mortality in the UK Biobank cohort: revisiting and evaluating risk factors]]></article-title>
<source><![CDATA[Eur J Epidemiol]]></source>
<year>2021</year>
<volume>36</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>299-309</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gallo Marin]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Aghagoli]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Lavine]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Yang]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Siff]]></surname>
<given-names><![CDATA[EJ]]></given-names>
</name>
<name>
<surname><![CDATA[Chiang]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
<name>
<surname><![CDATA[Salazar-Mather]]></surname>
<given-names><![CDATA[TP]]></given-names>
</name>
<name>
<surname><![CDATA[Dumenco]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Savaria]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[Aung]]></surname>
<given-names><![CDATA[SN]]></given-names>
</name>
<name>
<surname><![CDATA[Flanigan]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Michelow]]></surname>
<given-names><![CDATA[IC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Predictors of COVID-19 severity: A literature review]]></article-title>
<source><![CDATA[Rev Med Virol.]]></source>
<year>2021</year>
<volume>31</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1-10</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lauring]]></surname>
<given-names><![CDATA[AS]]></given-names>
</name>
<name>
<surname><![CDATA[Tenforde]]></surname>
<given-names><![CDATA[MW]]></given-names>
</name>
<name>
<surname><![CDATA[Chappell]]></surname>
<given-names><![CDATA[JD]]></given-names>
</name>
<name>
<surname><![CDATA[Gaglani]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ginde]]></surname>
<given-names><![CDATA[AA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study]]></article-title>
<source><![CDATA[BMJ]]></source>
<year>2022</year>
<volume>376</volume>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="">
<collab>Ministerio de Salud Pública y Bienestar Social</collab>
<source><![CDATA[Muertes maternas a causa de COVID-19 disminuyen 30%]]></source>
<year>2022</year>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gurzenda]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Castro]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[COVID-19 poses alarming pregnancy and postpartum mortality risk in Brazil]]></article-title>
<source><![CDATA[EClinicalMedicine]]></source>
<year>2021</year>
<volume>36</volume>
<page-range>100917</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[López-Rodríguez]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Galván]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Valencia]]></surname>
<given-names><![CDATA[ÓG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Comorbidities associated with maternal mortality from COVID-19 in Mexico]]></article-title>
<source><![CDATA[Gac Med Mex]]></source>
<year>2021</year>
<volume>157</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>599-603</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Frenkel]]></surname>
<given-names><![CDATA[LD]]></given-names>
</name>
<name>
<surname><![CDATA[Gomez]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Bellanti]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[COVID-19 in children: Pathogenesis and current status]]></article-title>
<source><![CDATA[Allergy Asthma Proc]]></source>
<year>2021</year>
<volume>42</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>8-15</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zhang]]></surname>
<given-names><![CDATA[QY]]></given-names>
</name>
<name>
<surname><![CDATA[Xu]]></surname>
<given-names><![CDATA[BW]]></given-names>
</name>
<name>
<surname><![CDATA[Du]]></surname>
<given-names><![CDATA[JB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Similarities and differences between multiple inflammatory syndrome in children associated with COVID-19 and Kawasaki disease: clinical presentations, diagnosis, and treatment]]></article-title>
<source><![CDATA[World J Pediatr.]]></source>
<year>2021</year>
<volume>17</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>335-40</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mouffak]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Shubbar]]></surname>
<given-names><![CDATA[Q]]></given-names>
</name>
<name>
<surname><![CDATA[Saleh]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[El-Awady]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Recent advances in management of COVID-19]]></article-title>
<source><![CDATA[A review. Biomed Pharmacother]]></source>
<year>2021</year>
<volume>143</volume>
<page-range>112107</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fathizadeh]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Afshar]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Masoudi]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[SARS-CoV-2 (Covid-19) vaccines structure, mechanisms and effectiveness: A review]]></article-title>
<source><![CDATA[Int J Biol Macromol]]></source>
<year>2021</year>
<volume>188</volume>
<page-range>740-50</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="">
<collab>Ministerio de Salud Pública y Bienestar Social</collab>
<source><![CDATA[Plan de Vacunacion - COVID-19]]></source>
<year></year>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
